Search Results - Con Panousis
- Showing 1 - 2 results of 2
-
1
A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab by Andrew McKenzie, Anthony Roberts, Sourabh Malandkar, Henrike Feuersenger, Con Panousis, Dipti Pawaskar
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure by Saw Yen Ow, Eugene A. Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J. Wilson, Andrew D. Nash, Matthias Pelzing
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book